Horizon Therapeutics Past Performance
How has Horizon Therapeutics performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HZNP has high quality earnings.
Growing Profit Margin: HZNP's current net profit margins (20.1%) are lower than last year (20.3%).
Past Earnings Growth Analysis
Earnings Trend: HZNP has become profitable over the past 5 years, growing earnings by 62.3% per year.
Accelerating Growth: HZNP's earnings growth over the past year (47.6%) is below its 5-year average (62.3% per year).
Earnings vs Industry: HZNP earnings growth over the past year (47.6%) exceeded the Biotechs industry 29.2%.
Return on Equity
High ROE: HZNP's Return on Equity (15.5%) is considered low.